Vital Annex: International Journal of Novel Research in Advanced Sciences
(IJNRAS)
Volume: 01 Issue: 05 | 2022 ISSN: 2751-756X
http://innosci.org
399 | Page
report
of
tolerability
and
efficacy
//
Arthritis
Rheum.
2003;48(7):2019-2024.
doi:10.1002/art.11163
8. Hickson LJ, Crowson CS, Gabriel SE, et al. Development of
reduced kidney function in
rheumatoid arthritis.
Am J Kidney Dis. 2014;63:206-13. doi: 0.1053/j.ajkd.2013.08.010
9. Helin HJ, Korpela MM, Mustonen JT, Pasternack AI.
Renal biopsy findings and
clinicopathologic correlations in rheumatoid arthritis.
Arth Rheum. 1995;38(2):242-7. doi:
10.1002/art.1780380213
10.
Helin H.J., Korpela M.M., Mustonen J.T., Pasternack A.I. Renal biopsy findings and
clinicopathologic correlations in rheumatoid arthritis // Arthritis Rheum. 1995. V. 38 (2). P.
242—247.
11. Hickson LJ, Crowson CS, Gabriel SE. Development of Reduced Kidney Function in
Rheumatoid Arthritis.
Am J Kidney Dis 2014;63(2): 206-213
12. Ifuku M., Miyake K., Watanebe M. et al. Various roles of Th cytokine mRNA expression in
different formsof glomerulonephritis.
Amer. J. Nephrol. 2013; 38 (2):115–123. DOI:
10.1159/000353102.
13. Imig J.D., Ryan M.J. Immune and inflammatory role in renal disease.
Compr. Physiol. 2013; 3
(2): 957–976.DOI: 10.1002/cphy.c120028
14. Ingrasciotta Y., Sultana J., Giorgianni F. et al. Association of Individual Non-Steroidal Anti-
Inflammatory Drugs and Chronic Kidney Disease: A Population-Based Case Control Study //
PLoS One. – 2015; 10 (4): e0122899. DOI: 10.1371/journal.pone.0122899.
15. Jesky M, Lambert A, Burden A. The impact of chronic kidney
disease and cardiovascular
comorbidity on mortality in a multiethnic population: a retrospective cohort study.
BMJ Open
2013;3(12). doi 10.1136/bmjopen-2013-003458
16. Joss N., McLaughlin K., Simpson K., Boulton-Jones J. M.// Q. J. Med.— 2000.— Vol. 93.— P.
535—542
.
17. Kapoor T, Bathon J. Renal manifestations of rheumatoid arthritis//Rheumatic Disease Clin-
ics.2018;44:4:571-584.doi:10.1016/j.rdc.2018.06.008
18. Kim HW, Lee CK, Cha HS, et al. Effect of anti-tumor necrosis factor alpha treatment of
rheumatoid arthritis and chronic kidney disease.
Rheumatol Int. 2015;35(4):727-34. doi:
10.1007/s00296-014-3146-4
19.
Khamroyeva Y.S. Early Diagnosis of Systemic Scleroderma // Procedia of Engineering and
Medical Sciences-2022. №01.P.31-38.
20. Kochi M, Kohagura K, Shiohira Y, et al. In-flammation as a
Risk of Developing Chronic
Kidney Disease in Rheumatoid Arthritis // PLOS ONE. 2016. doi:10.1371/journal.pone.016022
21.
Koseki Y., Terai C., Moriguchi M. et al. A prospective study of renal disease in patients with
early rheumatoid arthritis // Ann. Rheum. Dis. 2001. V. 60 (4). P. 327—331
22. Kurts Ch., Panzer U., Anders H.-J., Rees A.J. The immune system and kidney disease: basic
concepts and clinical implications.
Nature Rev. Immunol. 2013; 13: 738–753. DOI:
0.1038/nri3523
23. LV. Revmatoidnyj artrit kak osnovnaya prichina razvitiya AAamiloidoza.
Klinicheskaya
gerontologiya. 2009;15(2):14-20 (In Russ.)